We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

78 hedge funds and large institutions have $74.4M invested in abrdn Life Sciences Investors in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

4% more capital invested

Capital invested by funds: $71.9M → $74.4M (+$2.54M)

0.21% more ownership

Funds ownership: 20.76% → 20.97% (+0.21%)

0% more funds holding

Funds holding: 78 → 78 (0)

Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RL
RPO LLC
Connecticut
+$2.57M
2
SCM
Saba Capital Management
New York
+$1.89M
3
TJHA
Thomas J. Herzfeld Advisors
Florida
+$1.43M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$1.26M
5
AA
AQR Arbitrage
Connecticut
+$688K

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$2.01M
2
FHA
Flagship Harbor Advisors
Massachusetts
-$1.87M
3
LSC
Logan Stone Capital
Illinois
-$1.01M
4
WAM
Wolverine Asset Management
Illinois
-$978K
5
Wells Fargo
Wells Fargo
California
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJT
51
Raymond James Trust
Florida
$175K – – –
TPWM
52
Twelve Points Wealth Management
Massachusetts
$175K – – –
PIA
53
Powell Investment Advisors
Florida
$172K – – –
Cambridge Investment Research Advisors
54
Cambridge Investment Research Advisors
Iowa
$166K +$2.9K +210 +2%
BRWA
55
B. Riley Wealth Advisors
Florida
$159K +$69 +5 +0%
SI
56
Stephens Inc
Arkansas
$158K +$3.26K +236 +2%
SWP
57
Stratos Wealth Partners
Ohio
$155K +$3.56K +258 +2%
Millennium Management
58
Millennium Management
New York
$147K +$149K +10,829 New
IWM
59
IHT Wealth Management
Illinois
$142K +$3.24K +235 +2%
PA
60
Parallel Advisors
California
$135K +$980 +71 +0.7%
BBPWM
61
Blue Bell Private Wealth Management
Pennsylvania
$85.5K +$67.6K +4,900 +347%
GRP
62
Global Retirement Partners
California
$67.5K +$1.53K +111 +2%
CSPIA
63
Cary Street Partners Investment Advisory
Virginia
$52.7K – – –
CWC
64
Carolinas Wealth Consulting
North Carolina
$46.9K – – –
CFD
65
Creative Financial Designs
Indiana
$29.8K – – –
SPIA
66
Steward Partners Investment Advisory
New York
$20.6K +$455 +33 +2%
Carson Wealth (CWM LLC)
67
Carson Wealth (CWM LLC)
Nebraska
$15K +$1.16K +84 +8%
Bessemer Group
68
Bessemer Group
New Jersey
$13K – – –
PFG
69
Piershale Financial Group
Illinois
$11.4K +$262 +19 +2%
WBC
70
West Branch Capital
Massachusetts
$10.2K +$235 +17 +2%
BWS
71
Buck Wealth Strategies
Colorado
$6.51K +$152 +11 +2%
LFG
72
Larson Financial Group
Missouri
$5.81K – – –
WOSD
73
WFA of San Diego
California
$4.06K +$4.14K +300 New
ACA
74
Atlas Capital Advisors
Wyoming
$1.87K – – –
FCT
75
First Community Trust
Iowa
$1.35K – – –
1 2
3
4

HQL Hedge Fund Activity: Q2 2023 in Review

78 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2023, worth a combined $74.4M — up 3.5% from $71.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HQL positions and 7 closed out — a net gain of 1 holder — while 34 added to existing stakes and 19 trimmed.

The largest buyer was RPO LLC, opening a new position worth an estimated $2.57M. The largest seller was Raymond James & Associates, cutting an estimated $2.01M.

  • 78 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $74.4M of abrdn Life Sciences Investors stock for Q2 2023, up 3.5% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q2 2023 and 7 closed out, a net change of +1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q2 2023 was RPO LLC, an estimated $2.57M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2023 was Raymond James & Associates, an estimated $2.01M sold.

Based on aggregated 13F filings for Q2 2023.